Come hear all about the KCE and KCE trials, presented by Frank Hulstaert, MD, MSc - senior researcher at KCE.

The Belgian healthcare knowledge centre (KCE) became operational in 2004 and published nearly 400 reports. The projects concern health services research, health technology assessment and clinical practice guidelines. Most KCE reports include policy recommendations, approved by the KCE board. In 2016 KCE Trials started funding comparative effectiveness and drug repurposing clinical trials. The interventions studied include pharmaceuticals, medical devices, psychotherapy, diet, speech therapy, physiotherapy, etc. Over 50 trials have received funding so far.

About the speaker:

Frank Hulstaert studied medicine in Ghent (MD, 1985), informatics in Brussels (MSc) and biostatistics at Hasselt University, Belgium. He started a residency in internal medicine but soon turned to industry, where he worked at Applied Artificial Intelligence, IBM, Becton and Dickinson, Sandoz/Novartis and Innogenetics. He was mainly involved in the development of in vitro diagnostics, pharmaceuticals and biopharmaceuticals, as medical expert and later as medical director. He joined the Belgian Health Care Knowledge Centre (KCE) in 2004. As a senior researcher he is mainly involved in health technology assessments and since 2016 also in KCE Trials, a program of publicly funded practice-oriented trials. During the covid pandemic he coordinated the non-commercial covid clinical trials in Belgium.